Amagma, Inc. reported raising $2.28 Million in an initial SEC Form D filing, from an offering of $2.28 Million
Amount Raised
$2.28 Million
Round Type
Seed
Quick answer
Amagma, Inc. raised $2.28 Million in a Seed round, dated June 1, 2022. Amagma, Inc. is based in Waltham, Massachusetts, United States.
- How much did Amagma, Inc. raise?
- Amagma, Inc. raised $2.28 Million in a Seed round on June 1, 2022.
- What does Amagma, Inc. do?
- Amagma Therapeutics is a startup biotechnology company founded by proven serial entrepreneurs including Prof.
- Where is Amagma, Inc. based and how big is it?
- Amagma, Inc. is based in Waltham, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Amagma, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Renibus Therapeutics raised $15M on July 15, 2022.
- Greenbrook TMS raised $16M on July 14, 2022.
- Ensysce Biosciences raised $4.2M (Seed) on July 8, 2022.
- Kernal Biologics raised $25M (Series A) on July 7, 2022.
- X4 Pharmaceuticals raised $56M on July 6, 2022.
- Ascendia Pharmaceuticals raised $2.5M on July 1, 2022.
Who to call at Amagma, Inc., and when
A new round usually means Amagma, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amagma, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amagma, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amagma, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amagma, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Amagma, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.